Numbers
Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
The Numbers
Gopal Snacks trades at 95x trailing earnings because FY2025 was destroyed by a factory fire. The single metric that will rerate or derate this stock is operating margin recovery: if OPM returns to 9-10% (FY2024 levels), the stock is reasonably priced at ~35x normalized P/E. If margins stall at 5-6%, the stock is 70x+ a mediocre commodity processor.
Price ($)
Mkt Cap ($M)
P/E (Trailing)
Revenue FY25 ($M)
OPM FY25
Quality Scorecard
The balance sheet is healthy (near debt-free, strong current ratio, safe Altman Z zone). But profitability quality collapsed in FY2025 — ROE of 4.8% is far below cost of equity. The company was genuinely high-quality in FY2023 (48% ROE, 44% ROCE) but that was the peak of a favorable input-cost cycle, not sustainable earning power.
Revenue & Earnings Power
Revenue has compounded at 11% over 5 years with no declines, but operating income swings wildly — $19M peak to $5M trough, a 4.4x range. This is a commodity processor's earnings profile dressed up in FMCG clothing.
Margins range 3x (OPM: 3.2% to 11.4%). FY2023 was the cycle peak, not a new normal. Mid-cycle OPM is likely 6-8%.
Quarterly Recovery Tracker
Q3 FY2026 shows recovery ($2.3M op income vs $0.8M in Q3 FY2025) but is still well below Q1-Q2 FY2025 pre-fire levels ($3.9-4.4M). Full margin normalization is not yet achieved.
Cash Generation — Are the Earnings Real?
Cash conversion is actually healthy — operating cash flow exceeded net income in 4 of 5 years. FY2024 shows OCF below NI due to working capital buildup (inventory + receivables spike). The company is a genuine cash generator at the operating level; negative FCF years are driven by capex, not earnings fabrication.
FY2025 capex surge ($10M) reflects Gondal plant construction + fire restoration. This is investment capex, not maintenance — should yield operating leverage in FY2026-27.
Balance Sheet Health
The deleveraging story is dramatic: D/E dropped from 1.04 to 0.16 in four years, funded by IPO proceeds ($7.8M raised March 2024) and retained earnings. The balance sheet is now fortress-like for a small-cap food company.
Balance sheet transformed: $19.3M debt in FY2021 → $7.8M in FY2025, equity nearly tripled. Financial risk is minimal.
Working Capital Red Flag
Receivables exploded 4.8x from $2.4M (FY2023) to $11.2M (FY2024) without proportionate revenue growth. This demands explanation — possible channel stuffing or aggressive distributor credit.
Valuation
Limited valuation history (listed March 2024). Trailing P/E of 95.6x is meaningless due to fire-depressed FY2025 earnings. On normalized FY2024 earnings ($12M net profit), the stock trades at ~34x — reasonable for a mid-cap FMCG company but expensive for one with 3-11% OPM volatility.
Fair Value Scenario
At $3.18, the stock prices in the base case ($2.81 fair value) with slight optimism. The bull case requires both margin recovery AND multiple expansion. The bear case implies 54% downside if margins don't normalize.
Peer Comparison
Gopal's P/B of 8.2x looks expensive for a 4.8% ROE business. On normalized ROE (25%+), P/B is justified. The market is pricing in a full recovery that hasn't happened yet.
The numbers confirm a structurally healthy balance sheet and genuine operating cash generation, but contradict the FMCG-quality narrative — this is a commodity-margin business with 4x earnings cyclicality. Watch Q4 FY2026 OPM: if it prints above 8%, the recovery thesis holds and the stock is fairly priced. If it stalls below 6%, the 95x trailing P/E collapses toward the bear case.